Par Drugs and Chemicals Limited (NSE:PAR)

India · Delayed Price · Currency is INR

118.00

+4.83 (4.27%)

Nov 11, 2026, 2:15 PM IST

Par Drugs and Chemicals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,077	1,037	1,010	956.4	957.49	750.74
Revenue Growth	9.40%	2.66%	5.58%	-0.11%	27.54%	23.58%
Gross Profit	588.44	591.45	617.86	609.88	547.65	457.57
Operating Income	146.28	134.35	158.64	193.81	149.74	129.74
Net Income	129.91	131.09	133.58	145.01	113.34	92.13
Earnings Per Share	10.56	10.65	10.86	11.78	9.21	7.49
EPS Growth	34.11%	-1.90%	-7.84%	27.90%	23.00%	-20.64%

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Unallocated	8.57	4.27	5.34	6.54	8.74
India	747.49	752.29	718.17	751.19	562.73
Export	280.49	253.17	232.89	199.76	179.27
Total	1,037	1,010	956.4	957.49	750.74

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	363.62	418.43	275.77	366.54	222.43	162.06
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	363.62	418.43	275.77	366.54	222.43	162.06
Net Cash Growth	7.40%	51.73%	-24.76%	64.79%	37.25%	26.19%
Net Cash Per Share	29.56	34.01	22.41	29.79	18.08	13.17

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	164.32	161.6	202.49	133.77	76.15
Capital Expenditures	-	-19.62	-12.27	-60.8	-76.34	-32.02
Free Cash Flow	-	144.7	149.34	141.69	57.43	44.13
Free Cash Flow Growth	-	-3.10%	5.40%	146.69%	30.15%	-37.28%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	54.66%	57.06%	61.19%	63.77%	57.20%	60.95%
Operating Margin	13.59%	12.96%	15.71%	20.27%	15.64%	17.28%
Pretax Margin	15.93%	16.69%	17.75%	20.41%	15.75%	16.92%
Profit Margin	12.07%	12.65%	13.23%	15.16%	11.84%	12.27%
FCF Margin	-	13.96%	14.79%	14.81%	6.00%	5.88%

Dividends

Fiscal Year	FY 2022
Period Ending	Mar '22 Mar 31, 2022
Dividend Per Share	1.250
Dividend Per Share Growth	-
Dividend Yield	0.78%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 11, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	11.17	7.38	7.82	18.28	15.20	21.34
P/FCF Ratio	-	6.68	7.00	18.71	29.99	44.54
PS Ratio	1.28	0.93	1.03	2.77	1.80	2.62